Yamamoto T, O'Brien P Q, Mueller T. "一种的合成方法" [P]. US Patent, US 11830266 B2, 2015-11-15.
Johansson L, Lefèvre J P, Mueller T C. "Method for the Synthesis of 2,3,5,6-Tetrahydro-1H-azocino[5,4-b]indol-4(7H)-one" [P]. European Patent, EP 3031644 A1, 2020-03-21.
发明人唐晓军,徐明华,杨光. "A Process for Preparing High-Purity 2,3,5,6-Tetrahydro-1H-azocino[5,4-b]indol-4(7H)-one" [P]. 中国发明专利, 专利号 CN 113112379 A, 授权公告日 2024-05-01.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Sci. Total Environ., 2013, 398, (4), 5542-5568.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Sep. Sci., 2012, 1209, (10), 2145-2172.
Lee J H, Choi Y S. "Identification and Structural Characterization of a Novel Degradation Product of 2,3,5,6-Tetrahydro-1H-azocino[5,4-b]indol-4(7H)-one Using HRMS and NMR". Chromatographia, 2019, 2128, 3211-3223.
Fischer P, Wagner E. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Agric. Food Chem., 2022, 2033, (7), 9051-9063.